与起器相关的心力衰竭的长期死亡率和治疗结果:来自全国性倾向匹配研究的见解
Young Jun Park1, Sungjoo Lee2, Sungjun Hong2,3
1Division of Cardiology, Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Republic of Korea.
European heart journal open
|March 9, 2026
概括
心脏再同步治疗 (CRT) 升级显著降低了与节奏相关的心力衰竭 (PaHF) 患者的死亡率. 这种基于设备的治疗,结合心力衰竭药物,改善了现实环境中的生存率.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 公共卫生 公共卫生
背景情况:
- 节拍相关心力衰竭 (PaHF) 是一个日益关注的节拍器患者.
- 预后因素和PaHF的最佳管理尚未得到充分理解.
- 关于PaHF结果的现实数据有限.
研究的目的:
- 评估PaHF患者的死亡风险.
- 评估心脏再同步治疗 (CRT) 升级对生存的影响.
- 为了确定心力衰竭 (HF) 药物对PaHF结果的影响.
主要方法:
- 全国范围内的真实世界队列 (n=4166) 患者的分析,这些患者在心脏起器植入后发展了PaHF.
- 应用倾向得分匹配和时间依赖的考克斯回归来缓解偏差.
- 接受CRT升级加上HF药物治疗的患者与仅服用HF药物治疗的患者之间的结局的比较.
主要成果:
- 增加年龄,男性性别,糖尿病和慢性病与较高的全因死亡率有关.
- 通过CRT升级,所有原因死亡率显著降低 (HR=0.36).
- ангиотензин受体-neprilysin抑制剂 (ARNI) 和β-阻断剂与改善的生存率有关.
结论:
- 与单独的药物治疗相比,CRT升级显著降低了PaHF患者的全因死亡率.
- 基于设备的治疗,包括CRT升级,对于管理PaHF至关重要.
- 将CRT升级与当代高频医学治疗相结合,可以在现实实践中提高生存率.
相关概念视频
Cardiomyopathy V: Interprofessional Care
566
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Cardiomyopathy II: Dilated Cardiomyopathy
695
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695
Cardiomyopathy III: Hypertrophic Cardiomyopathy
602
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
Heart Failure VI: Adjunct Therapies
493
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
493
Heart Failure V: Medical Management
453
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
453
Cardiomyopathy VI: Nursing Management
431
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
431


